Efficacy and safety of docetaxel (Taxotere&unknown;) in heavily pretreated advanced breast cancer patients - a national cancer institute treatment referral center trial

Author： Bonneterre J.   Spielman M.   Guastalla J.-P.   Marty M.   Viens P.   Chollet P.   Roche H.   Fumoleau P.   Mauriac L.   Bourgeois H.   Namer M.   Bergerat J.P.   Misset J.-L.   Trandafir L.   Mahjoubi M.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.35, Iss.10, 1999-10, pp. : 1431-1439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer

By Osako Tomo   Ito Yoshinori   Takahashi Shunji   Tokudome Nahomi   Iwase Takuji   Hatake Kiyohiko  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 159-164

Springer Publishing Company

Access to resources Recommend Favorite

Treatment with Formestane Alone and in Combination with Aminoglutethimide in Heavily Pretreated Breast Cancer Patients: Clinical and Endocrine Effects

By Geisler J.   Johannessen D.C.   Anker G.   Lonning P.E.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 789-792

Elsevier

Access to resources Recommend Favorite

Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer

By Larsen Finn Ole   Boisen Mogens Karsbøl   Fromm Annelene L.   Jensen Benny Vittrup  

Acta Oncologica, Vol. 51, Iss. 2, 2012-02 ,pp. : 231-233

Informa Healthcare

Access to resources Recommend Favorite

A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study

By Diéras Véronique   Guastalla Jean   Ferrero Jean   Curé Hervé   Weber Béatrice   Winckel Philippe   Lortholary Alain   Mayer Françoise   Paraiso Désiré   Magherini Emmanuelle   Pujade-Lauraine Eric  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 6, 2004-06 ,pp. : 489-495

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel (taxotere(R)) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer

By Le Chevalier T.   Monnier A.   Douillard J.Y.   Ruffie P.   Sun X.S.   Belli L.   Ibrahim N.   Bougon N.   Berille J.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2032-2036

Elsevier

Access to resources Recommend Favorite